Prophylaxis to combat HIV infection after sexual exposure
Article Abstract:
The expanding use of prophylaxis drugs to treat people who have been exposed to possible HIV infection through sexual activities needs to be debated at a national level so as to develop a medical standard. Postsexual exposure prophylaxis (PSEP) drugs have been successful in preventing infection by the HIV virus after sex, although this success has lead to a charge of undermining safe sex education. The use of PSEP must be properly regulated to ensure it benefits the health of the nation, rather than harming it.
Publication Name: Nursing Times
Subject: Health
ISSN: 0954-7762
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
A Review of Abacavir and Efavirenz: New Antiretroviral Drugs to Treat HIV-1 Infection
Article Abstract:
Abacavir (Ziagen) and efavirenz (Sustiva) have been approved for use in combating HIV. Adverse reactions to abacavir include nausea, fever, and skin rash. Adverse reactions to efavirenz include skin rash, nausea, dizziness, nervousness, and other reactions to the nervous system. Treatment decisions for such highly active antiretroviral drugs should be made carefully, with an understanding of pharmacokinetics and patient adherence habits.
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The mixed message. Nutrition and HIV infection. Romania: a unique experience
- Abstracts: High ideals. Paternalistic intervention in mental health care. Italian ideals: Italy pioneered care in the community for people with mental health problems. What can UK nurses learn from their Italian colleagues?
- Abstracts: Patient consent for publication and the health of the public. Obtain informed consent before publishing information about patients
- Abstracts: Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid: a randomized controlled trial